Terns Pharmaceuticals, Inc.

7.60 USD
-0.39 (-4.88%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Terns Pharmaceuticals, Inc. stock is up 33.33% since 30 days ago. The next earnings date is Mar 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 1 CALL, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jan 15:59 16 Feb, 2024 5.00 CALL 150 154
13 Feb 17:25 19 Jul, 2024 7.50 PUT 200 21

About Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.